Respiratory Diagnostics Inc

Abbott to acquire Alere for $5.8 billion

Abbott said that it has signed a definitive deal to acquire Alere for a net value of $5.8 billion in cash. Abbott expects the acquisition to be immediately accretive to its earnings per share upon completion.

Read Full Article

US firm Mederi Therapeutics bags $18.5M in Series B for GERD and bowel incontinence treatment

Connecticut, US-based pharmaceutical firm Mederi Therapeutics raised $18.5 million in a Series B funding round for the sales and marketing of its treatment for Gastrointestinal Reflux Disease (GERD) and fecal incontinence.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics